What Researchers Did
Researchers retrospectively reviewed medical records of 21 patients treated for maxillary bone osteoradionecrosis (ORN) with hyperbaric oxygen therapy (HBOT) at a single center from 1999 to 2015.
What They Found
Hyperbaric oxygen therapy (HBOT) resulted in a positive clinical outcome in 85.7% of patients with maxillary bone osteoradionecrosis (ORN). Radiological improvement was observed in 14 of 15 patients (93.3%). Five patients subsequently required reconstructive surgery.
What This Means for Canadian Patients
Canadian patients with maxillary bone osteoradionecrosis might benefit from hyperbaric oxygen therapy as a potential treatment option. This therapy could help improve clinical outcomes and reduce the need for more invasive procedures like reconstructive surgery in some cases.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at a single center outside of Canada.
Study Limitations
This study's findings are limited by its retrospective, single-center design and relatively small sample size.